Abstract:
The phyto-extract DsCE-Ⅰprepared from the tuber of Dioscorea plant can increase activities of a NF-B-inducible ELAM-1 composite promoter and a GM-CSF promoter and help test animals to fight against certain cancers in test mice. This extract may be used to improve the immune system for treating pathogen-infection and certain malignancies, and for recovery from physical/chemical damage.
Fields of Application:
1. This invention relates to a medicinal herb extract prepared from Dioscorea tuber and its use for improving specific immune systems, and for immuno-therapy against certain infections and cancers. 2. As an adjuvant, DsCE-Ⅰcan be used to enhance the immune response to an antigen of a vaccine formulation. 3. The DsCE-Ⅰadjuvant formulation may be used in a vaccine formulation to help immunize an animal. 4. A component of this invention can be used as a pharmaceutical formulation that contains a pharmaceutically acceptable carrier, such as a solvent, a dispersion medium, a coating, an antibacterial and antifungal agent, and an isotonic and absorption delaying agent. 5. An above-described the composition can be formulated to be compatible with its intended route of administration, e.g., oral administration. 6. The above-described extract or composition can be used as a medicament for treatment of immune system impairment. 7. The composition of invention can also used to therapeutically treat a condition treatable by a cell-mediated immune response. 8. The invention also can provid a method in treating a viral infection in an animal and a method of treating some neoplastic diseases in an animal comprising administering a therapeutically effective amount of immunogenic composition of the invention to the animal.
Advantages when compared to the existing technologies:
1. The procedure to make and manufacture the the Dioscorea extract (DsCE-Ⅰ) is much simpler than other current protein (e.g., cytokine) adjuvants for improving the immune systems. 2. As an adjuvant for cancer therapy, this invention claims that the cost of producing DsCE-Ⅰis much cheaper than the current adjuvant therapy such as G-CSF. 3. This invention claims that the above-described extract can used as a dietary supplement, health food, health drink or a pharmaceutical composition without toxicity for prevention of immune system impairment.
Contact Person:Mei-Ching Chen Tel: 886-2-27872511; Fax: 886-2-26518049; E-mail: cmj@gate.sinica.edu.tw
IP Status:US pending; TW pending
